XTNT (STOCKS)
Xtant Medical Holdings, Inc.
$0.476400
-0.003600 (-0.75%)
Prev close: $0.480000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Sean E. Browne
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $67.91M
- Employees
- 232
- P/E (TTM)
- 14.50
- P/B (TTM)
- 1.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.00 | $-0.01 | +0.0051 | +100.00% |
|
Sep 2025 (Q3)
|
$0.01 | $-0.01 | +0.0151 | +296.08% |
|
Jun 2025 (Q2)
|
$0.02 | $-0.01 | +0.0302 | +296.08% |
|
Mar 2025 (Q1)
|
$0.00 | $-0.01 | +0.0102 | +100.00% |
Financial Statements
| Revenues | $133.93M |
| Benefits Costs and Expenses | $126.93M |
| Cost Of Revenue | $49.65M |
| Costs And Expenses | $126.93M |
| Gross Profit | $84.27M |
| Nonoperating Income/Loss | -$283.00K |
| Operating Expenses | $76.99M |
| Research and Development | $2.10M |
| Other Operating Expenses | $74.89M |
| Operating Income/Loss | $7.28M |
| Income/Loss From Continuing Operations After Tax | $4.97M |
| Income/Loss From Continuing Operations Before Tax | $7.00M |
| Income Tax Expense/Benefit | $2.03M |
| Income Tax Expense/Benefit, Current | $2.07M |
| Income Tax Expense/Benefit, Deferred | -$38.00K |
| Interest Expense, Operating | $3.67M |
| Net Income/Loss | $4.97M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $4.97M |
| Net Income/Loss Available To Common Stockholders, Basic | $4.97M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.04 |
| Diluted Earnings Per Share | $0.03 |
| Basic Average Shares | 139,531,791 |
| Diluted Average Shares | 150,042,556 |
| Assets | $94.15M |
| Current Assets | $78.25M |
| Inventory | $30.26M |
| Other Current Assets | $47.98M |
| Noncurrent Assets | $15.90M |
| Fixed Assets | $6.20M |
| Intangible Assets | $299.00K |
| Other Non-current Assets | $9.40M |
| Liabilities | $43.19M |
| Current Liabilities | $29.48M |
| Accounts Payable | $3.84M |
| Other Current Liabilities | $25.64M |
| Noncurrent Liabilities | $13.71M |
| Long-term Debt | $11.03M |
| Other Non-current Liabilities | $2.68M |
| Equity | $50.95M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $50.95M |
| Liabilities And Equity | $94.15M |
| Net Cash Flow From Operating Activities | $12.55M |
| Net Cash Flow From Operating Activities, Continuing | $12.55M |
| Net Cash Flow From Investing Activities | $7.90M |
| Net Cash Flow From Investing Activities, Continuing | $7.90M |
| Net Cash Flow From Financing Activities | -$9.57M |
| Net Cash Flow From Financing Activities, Continuing | -$9.57M |
| Net Cash Flow | $10.88M |
| Net Cash Flow, Continuing | $10.88M |
| Comprehensive Income/Loss | $5.29M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $5.29M |
| Other Comprehensive Income/Loss | $5.29M |